Screener
BridgeBio Pharma BBIO Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from BridgeBio Pharma’s reported figures.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
FAQ
- What is BridgeBio Pharma's enterprise value?
- BridgeBio Pharma (BBIO) reported enterprise value of $16.77B in Q1 2026.
- How has BridgeBio Pharma's enterprise value changed year-over-year?
- BridgeBio Pharma's enterprise value increased by 177.6% year-over-year, from $6.04B to $16.77B.
- What is the long-term trend for BridgeBio Pharma's enterprise value?
- Over 5 years (2020 to 2025), BridgeBio Pharma's enterprise value has grown at a 7.4% compound annual growth rate (CAGR), from $10.22B to $14.58B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about BridgeBio Pharma's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude